 Ivacaftor is a medication taken by mouth for the treatment of CF due to a number of specific mutations responsive to ivacaftor-induced CFTR protein enhancement.It improves lung function by about 10%; however, it is expensive.The first year it was on the market, the list price was over $300,000 per year in the United States.